<!DOCTYPE html>
<html lang="en" data-arca>
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Phase III — Benefit-Risk Analysis Solutions | ArcaScience</title>
  <meta name="description" content="ArcaScience's AI-driven benefit-risk analysis platform for Phase III drug development. Integrate pivotal trial data with real-world evidence to produce quantified benefit-risk assessments aligned with FDA and EMA expectations.">

  <link rel="preload" href="/fonts/Inter-Variable.woff2" as="font" type="font/woff2" crossorigin>
  <link rel="preload" href="/fonts/Literata-Variable.woff2" as="font" type="font/woff2" crossorigin>

  <link rel="stylesheet" href="/dist/arcascience-global.min.css">

  <script>
    (function(){
      if(window.matchMedia&&window.matchMedia('(prefers-reduced-motion: reduce)').matches){
        document.documentElement.classList.add('reduced-motion');
      }
    })();
  </script>
</head>
<body>

  <div data-scroll-progress></div>

  <nav class="arca-nav" data-nav="sticky" role="navigation" aria-label="Main navigation">
    <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px; display: flex; align-items: center; justify-content: space-between; height: 100%;">
      <a href="/" aria-label="ArcaScience home">
        <img src="/images/arcascience-logo.svg" alt="ArcaScience" height="32">
      </a>
      <div style="display: flex; align-items: center; gap: 32px;">
        <a href="/" class="arca-nav-link">Home</a>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/platform-overview" class="arca-nav-link">Platform <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 260px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/platform-overview" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Platform Overview</a>
            <a href="/platform-how-it-works" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">How It Works</a>
            <a href="/platform-data-intelligence" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Data Intelligence</a>
            <a href="/platform-ai-models" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">AI Models</a>
            <a href="/platform-outputs" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Regulatory Outputs</a>
            <a href="/platform-integrations" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Integrations</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <a href="/security-compliance" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Security &amp; Compliance</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/solution-therapeutic-area" class="arca-nav-link is-active">Solutions <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 260px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">By Approach</p>
            <a href="/solution-therapeutic-area" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Therapeutic Area</a>
            <a href="/solution-lifecycle-phase" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Lifecycle Phase</a>
            <a href="/solution-role" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">By Role</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">By Stage</p>
            <a href="/solution-early-development" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Early Development</a>
            <a href="/solution-late-development" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Late Development</a>
            <a href="/solution-post-marketing" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Post-Marketing</a>
            <a href="/solution-market-access" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Market Access</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <p style="padding: 6px 16px 4px; font-size: 0.6875rem; font-weight: 600; letter-spacing: 0.08em; text-transform: uppercase; color: var(--grey-400); margin: 0;">Therapeutic Areas</p>
            <a href="/ta-oncology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Oncology</a>
            <a href="/ta-neurology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Neurology</a>
            <a href="/ta-immunology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Immunology</a>
            <a href="/ta-cardiology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Cardiology</a>
            <a href="/ta-respiratory" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Respiratory</a>
            <a href="/ta-rare-diseases" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Rare Diseases</a>
            <a href="/ta-dermatology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Dermatology</a>
            <a href="/ta-hematology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Hematology</a>
            <a href="/ta-gastroenterology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Gastroenterology</a>
            <a href="/ta-endocrinology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Endocrinology</a>
            <a href="/ta-infectious-disease" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Infectious Disease</a>
            <a href="/ta-pediatrics" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Pediatrics</a>
          </div>
        </div>

        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/evidence-case-studies-hub" class="arca-nav-link">Evidence <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 220px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/evidence-case-studies-hub" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Case Studies</a>
            <a href="/evidence-publications" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Publications</a>
            <a href="/evidence-metrics" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Platform Metrics</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/about" class="arca-nav-link">Company <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; left: -12px; min-width: 200px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/about" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">About ArcaScience</a>
            <a href="/leadership" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Leadership</a>
            <a href="/careers" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Careers</a>
            <a href="/science-methodology" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Science &amp; Methodology</a>
          </div>
        </div>
        <div style="position: relative;" class="arca-nav-dropdown-wrap">
          <a href="/resources" class="arca-nav-link">Resources <svg width="10" height="6" viewBox="0 0 10 6" fill="none" style="margin-left: 4px; vertical-align: middle;"><path d="M1 1L5 5L9 1" stroke="currentColor" stroke-width="1.5" stroke-linecap="round" stroke-linejoin="round"/></svg></a>
          <div class="arca-nav-dropdown" style="position: absolute; top: 100%; right: -12px; min-width: 220px; padding: 8px 0; background: rgba(255,255,255,0.97); backdrop-filter: blur(12px); -webkit-backdrop-filter: blur(12px); border: 1px solid rgba(209,213,222,0.5); border-radius: 12px; box-shadow: 0 4px 12px rgba(0,0,0,0.06), 0 12px 32px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-8px); transition: opacity 200ms ease, transform 200ms ease, visibility 200ms; z-index: 100;">
            <a href="/resources" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Resource Hub</a>
            <a href="/resources-whitepapers" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Whitepapers</a>
            <a href="/resources-webinars" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Webinars &amp; Events</a>
            <div style="height: 1px; background: linear-gradient(90deg, transparent, rgba(35,86,160,0.15), transparent); margin: 6px 12px;"></div>
            <a href="/resources-faq" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">FAQ</a>
            <a href="/resources-glossary" style="display: block; padding: 8px 16px; font-size: 0.875rem; color: var(--grey-800); text-decoration: none; border-radius: 6px; margin: 0 4px; transition: background 150ms ease;">Glossary</a>
          </div>
        </div>
      </div>
      <a href="/contact" class="arca-btn-primary" style="height: 40px; padding: 8px 24px; font-size: 0.875rem;">
        Talk to a Scientist
      </a>
    </div>
  </nav>

  <div style="height: var(--nav-height);"></div>

  <main role="main">

    <section class="arca-bg-blue-900" style="position: relative; overflow: hidden; padding: var(--space-8) 0 var(--space-10);" data-animate>
<!-- arca-decor-injected -->
      <!-- arca-decor: glow orbs -->
      <div style="position: absolute; top: -100px; right: -100px; width: 500px; height: 500px; background: radial-gradient(circle, rgba(67, 56, 202, 0.12) 0%, transparent 70%); border-radius: 50%; filter: blur(60px); pointer-events: none; animation: as-float 8s ease-in-out infinite; z-index: 0;"></div>
      <div style="position: absolute; bottom: -80px; left: -80px; width: 400px; height: 400px; background: radial-gradient(circle, rgba(59, 125, 216, 0.06) 0%, transparent 70%); border-radius: 50%; filter: blur(60px); pointer-events: none; animation: as-float 10s ease-in-out infinite reverse; z-index: 0;"></div>

    <!-- arca-decor: timeline SVG -->
    <svg width="460" height="200" viewBox="0 0 460 200" fill="none" aria-hidden="true" style="position: absolute; right: 0; bottom: 20px; opacity: 0.1; pointer-events: none; z-index: 0;">
      <line x1="40" y1="100" x2="420" y2="100" stroke="rgba(67,56,202,0.4)" stroke-width="2" stroke-dasharray="6 4"/>
      <circle cx="80" cy="100" r="8" stroke="rgba(67,56,202,0.5)" stroke-width="1.5" fill="rgba(67,56,202,0.1)"/>
      <circle cx="160" cy="100" r="8" stroke="rgba(67,56,202,0.5)" stroke-width="1.5" fill="rgba(67,56,202,0.1)"/>
      <circle cx="240" cy="100" r="12" stroke="rgba(67,56,202,0.6)" stroke-width="2" fill="rgba(67,56,202,0.15)"/>
      <circle cx="320" cy="100" r="8" stroke="rgba(67,56,202,0.5)" stroke-width="1.5" fill="rgba(67,56,202,0.1)"/>
      <circle cx="400" cy="100" r="8" stroke="rgba(67,56,202,0.5)" stroke-width="1.5" fill="rgba(67,56,202,0.1)"/>
      <path d="M80 80 L80 50" stroke="rgba(67,56,202,0.2)" stroke-width="1"/>
      <path d="M160 80 L160 60" stroke="rgba(67,56,202,0.15)" stroke-width="1"/>
      <path d="M240 75 L240 40" stroke="rgba(67,56,202,0.25)" stroke-width="1"/>
      <path d="M320 80 L320 60" stroke="rgba(67,56,202,0.15)" stroke-width="1"/>
      <path d="M400 80 L400 50" stroke="rgba(67,56,202,0.2)" stroke-width="1"/>
      <rect x="65" y="35" width="30" height="14" rx="2" stroke="rgba(67,56,202,0.2)" stroke-width="0.5" fill="none"/>
      <rect x="225" y="25" width="30" height="14" rx="2" stroke="rgba(67,56,202,0.3)" stroke-width="0.5" fill="none"/>
      <rect x="385" y="35" width="30" height="14" rx="2" stroke="rgba(67,56,202,0.2)" stroke-width="0.5" fill="none"/>
    </svg>

      <div style="position: relative; z-index: 1; max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">

        <nav aria-label="Breadcrumb" style="margin-bottom: var(--space-5);">
          <ol style="list-style: none; padding: 0; margin: 0; display: flex; align-items: center; gap: 8px; font-size: 0.75rem;">
            <li><a href="/" style="color: rgba(255,255,255,0.65); text-decoration: none;">Home</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li><a href="/solution-therapeutic-area" style="color: rgba(255,255,255,0.65); text-decoration: none;">Solutions</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li><a href="/solution-lifecycle-phase" style="color: rgba(255,255,255,0.65); text-decoration: none;">By Lifecycle Phase</a></li>
            <li style="color: rgba(255,255,255,0.4);">/</li>
            <li style="color: var(--white);">Phase III</li>
          </ol>
        </nav>

        <div style="max-width: 820px; margin: 0 auto; text-align: center;">
          <p class="arca-label arca-text-blue-400" style="margin-bottom: var(--space-3);">
            Drug Lifecycle Phase
          </p>
          <h1 class="arca-display-lg arca-text-white" style="margin-bottom: var(--space-5);">
            Submission-Ready Benefit-Risk Analysis for Pivotal Trials
          </h1>
          <p class="arca-body-lg" style="color: rgba(255,255,255,0.85); margin-bottom: var(--space-7); max-width: 680px; margin-left: auto; margin-right: auto;">
            Integrate pivotal efficacy and safety data with real-world evidence to produce quantified benefit-risk assessments aligned with FDA and EMA expectations. At this critical stage, structured benefit-risk analysis is essential to navigate regulatory expectations, manage safety signals, demonstrate clinical value, and inform go/no-go decisions with quantitative evidence.
          </p>
          <a href="/contact?source=phase-3" class="arca-btn-primary-inverted">
            Request Phase III-Specific Demo
          </a>
        </div>

      </div>
    </section>
    <div class="arca-section-divider" aria-hidden="true"></div>


    <section class="arca-bg-grey-50 arca-bg-cross" style="padding: var(--space-8) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-6);">
          <p class="arca-section-label">Drug Development Lifecycle</p>
          <h2 class="arca-heading-2" style="margin-bottom: var(--space-3);">
            Where Phase III Sits in the Drug Development Journey
          </h2>
        </div>

        <div style="display: grid; grid-template-columns: repeat(6, 1fr); gap: 12px; position: relative;">

          <div style="position: absolute; top: 24px; left: 8.33%; right: 8.33%; height: 2px; background: linear-gradient(to right, var(--grey-300) 0%, var(--grey-300) 100%); z-index: 0;"></div>

          <div class="arca-card arca-lifecycle-phase-card" data-phase="preclinical-phase-1" style="position: relative; z-index: 1; text-align: center; padding: var(--space-3);">
            <div class="arca-phase-indicator" style="width: 40px; height: 40px; border-radius: 50%; border: 3px solid var(--grey-300); background: var(--white); margin: 0 auto var(--space-2); display: flex; align-items: center; justify-content: center; font-weight: 600; font-size: 0.875rem; color: var(--grey-600);">1</div>
            <h3 class="arca-caption" style="font-weight: 600; margin-bottom: 4px;">Preclinical &amp; Phase I</h3>
            <p class="arca-caption arca-text-grey-600" style="font-size: 0.625rem;">Early safety signals</p>
          </div>

          <div class="arca-card arca-lifecycle-phase-card" data-phase="phase-2" style="position: relative; z-index: 1; text-align: center; padding: var(--space-3);">
            <div class="arca-phase-indicator" style="width: 40px; height: 40px; border-radius: 50%; border: 3px solid var(--grey-300); background: var(--white); margin: 0 auto var(--space-2); display: flex; align-items: center; justify-content: center; font-weight: 600; font-size: 0.875rem; color: var(--grey-600);">2</div>
            <h3 class="arca-caption" style="font-weight: 600; margin-bottom: 4px;">Phase II</h3>
            <p class="arca-caption arca-text-grey-600" style="font-size: 0.625rem;">Dose finding &amp; efficacy</p>
          </div>

          <div class="arca-card arca-lifecycle-phase-card is-current-phase" data-phase="phase-3" style="position: relative; z-index: 1; text-align: center; padding: var(--space-3); border-color: var(--indigo-500); background: var(--indigo-50);">
            <div class="arca-phase-indicator" style="width: 40px; height: 40px; border-radius: 50%; border: 3px solid var(--indigo-500); background: var(--indigo-500); margin: 0 auto var(--space-2); display: flex; align-items: center; justify-content: center; font-weight: 600; font-size: 0.875rem; color: var(--white);">3</div>
            <h3 class="arca-caption" style="font-weight: 600; margin-bottom: 4px;">Phase III</h3>
            <p class="arca-caption arca-text-grey-600" style="font-size: 0.625rem;">Confirmatory trials</p>
          </div>

          <div class="arca-card arca-lifecycle-phase-card" data-phase="regulatory-submission" style="position: relative; z-index: 1; text-align: center; padding: var(--space-3);">
            <div class="arca-phase-indicator" style="width: 40px; height: 40px; border-radius: 50%; border: 3px solid var(--grey-300); background: var(--white); margin: 0 auto var(--space-2); display: flex; align-items: center; justify-content: center; font-weight: 600; font-size: 0.875rem; color: var(--grey-600);">4</div>
            <h3 class="arca-caption" style="font-weight: 600; margin-bottom: 4px;">Regulatory Submission</h3>
            <p class="arca-caption arca-text-grey-600" style="font-size: 0.625rem;">NDA/BLA/MAA filing</p>
          </div>

          <div class="arca-card arca-lifecycle-phase-card" data-phase="post-marketing" style="position: relative; z-index: 1; text-align: center; padding: var(--space-3);">
            <div class="arca-phase-indicator" style="width: 40px; height: 40px; border-radius: 50%; border: 3px solid var(--grey-300); background: var(--white); margin: 0 auto var(--space-2); display: flex; align-items: center; justify-content: center; font-weight: 600; font-size: 0.875rem; color: var(--grey-600);">5</div>
            <h3 class="arca-caption" style="font-weight: 600; margin-bottom: 4px;">Post-Marketing</h3>
            <p class="arca-caption arca-text-grey-600" style="font-size: 0.625rem;">Continuous surveillance</p>
          </div>

          <div class="arca-card arca-lifecycle-phase-card" data-phase="market-access-hta" style="position: relative; z-index: 1; text-align: center; padding: var(--space-3);">
            <div class="arca-phase-indicator" style="width: 40px; height: 40px; border-radius: 50%; border: 3px solid var(--grey-300); background: var(--white); margin: 0 auto var(--space-2); display: flex; align-items: center; justify-content: center; font-weight: 600; font-size: 0.875rem; color: var(--grey-600);">6</div>
            <h3 class="arca-caption" style="font-weight: 600; margin-bottom: 4px;">Market Access &amp; HTA</h3>
            <p class="arca-caption arca-text-grey-600" style="font-size: 0.625rem;">Reimbursement &amp; value</p>
          </div>

        </div>

      </div>
    </section>

        <div class="arca-section-divider" aria-hidden="true"></div>

<section class="arca-bg-indigo-100 arca-bg-cross" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-8);">
          <p class="arca-section-label">Key Challenges</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-4);">
            Benefit-Risk Analysis Challenges at Phase III
          </h2>
          <p class="arca-body-lg arca-text-grey-600" style="max-width: 680px; margin: 0 auto;">
            Each development phase brings unique benefit-risk assessment challenges. Here's what pharmaceutical teams face during Phase III.
          </p>
        </div>

        <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 24px;">

          <div class="arca-card" data-animate>
            <div style="width: 48px; height: 48px; border-radius: 8px; background: var(--indigo-50); display: flex; align-items: center; justify-content: center; margin-bottom: var(--space-4);">
              <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="var(--indigo-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <circle cx="12" cy="12" r="10"/><line x1="12" y1="8" x2="12" y2="12"/><line x1="12" y1="16" x2="12.01" y2="16"/>
              </svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">Integrating Pivotal Trial Data with External Evidence</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Phase III trials generate large volumes of efficacy and safety data that must be contextualized within the broader evidence landscape. Integrating pivotal trial results with real-world evidence, published literature, spontaneous reporting databases, and comparator data is time-intensive and requires sophisticated data harmonization. Without comprehensive integration, benefit-risk assessments lack the external validity required for regulatory review and advisory committee presentations.
            </p>
          </div>

          <div class="arca-card" data-animate>
            <div style="width: 48px; height: 48px; border-radius: 8px; background: var(--indigo-50); display: flex; align-items: center; justify-content: center; margin-bottom: var(--space-4);">
              <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="var(--indigo-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <path d="M21 16V8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16z"/><polyline points="3.27 6.96 12 12.01 20.73 6.96"/><line x1="12" y1="22.08" x2="12" y2="12"/>
              </svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">Meeting Evolving Regulatory Expectations</h3>
            <p class="arca-body-sm arca-text-grey-600">
              FDA and EMA increasingly expect structured, quantitative benefit-risk assessments for NDA/BLA/MAA submissions. The FDA's BRAT framework and EMA's Effects Table methodology require specific formats, transparent weighting of benefit and risk criteria, and sensitivity analyses. Manual preparation of these structured assessments is resource-intensive and prone to inconsistencies that trigger regulatory questions during review.
            </p>
          </div>

          <div class="arca-card" data-animate>
            <div style="width: 48px; height: 48px; border-radius: 8px; background: var(--indigo-50); display: flex; align-items: center; justify-content: center; margin-bottom: var(--space-4);">
              <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="var(--indigo-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <polyline points="22 12 18 12 15 21 9 3 6 12 2 12"/>
              </svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">Advisory Committee Preparation</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Advisory committee meetings require quantitative benefit-risk presentations that are accessible to non-specialist panelists, defensible under expert questioning, and aligned with patient perspective considerations. Traditional narrative approaches struggle to communicate complex trade-offs. Sponsors need forest plots, effects tables, value trees, and scenario analyses that clearly demonstrate favorable benefit-risk balance across diverse stakeholder perspectives—clinical, patient, regulatory.
            </p>
          </div>

          <div class="arca-card" data-animate>
            <div style="width: 48px; height: 48px; border-radius: 8px; background: var(--indigo-50); display: flex; align-items: center; justify-content: center; margin-bottom: var(--space-4);">
              <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="var(--indigo-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <path d="M14 2H6a2 2 0 0 0-2 2v16a2 2 0 0 0 2 2h12a2 2 0 0 0 2-2V8z"/><polyline points="14 2 14 8 20 8"/><line x1="16" y1="13" x2="8" y2="13"/><line x1="16" y1="17" x2="8" y2="17"/><polyline points="10 9 9 9 8 9"/>
              </svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-3);">Subpopulation Benefit-Risk Variability</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Benefit-risk profiles often differ by age, sex, race, comorbidity, disease severity, and geographic region. Phase III trials must assess whether the overall favorable benefit-risk translates consistently across all subpopulations or whether certain groups experience disproportionate risk. Regulatory agencies increasingly scrutinize subpopulation analyses for signals of differential benefit-risk, requiring sponsors to identify and characterize these variations before approval.
            </p>
          </div>

        </div>
      </div>
    </section>
    <div class="arca-section-divider" aria-hidden="true"></div>


    <section class="arca-bg-grey-50 arca-bg-cross" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-8);">
          <p class="arca-section-label">ArcaScience for Phase III</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-4);">
            How the Platform Addresses Phase III BRA Challenges
          </h2>
          <p class="arca-body-lg arca-text-grey-600" style="max-width: 680px; margin: 0 auto;">
            ArcaScience's three integrated modules provide end-to-end benefit-risk analysis capabilities specifically tailored to Phase III requirements.
          </p>
        </div>

        <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px;">

          <div class="arca-card arca-card-colored-top is-data" data-animate>
            <span class="arca-module-tag is-data">Data Intelligence</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">
              Data Intelligence for Phase III
            </h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">
              Seamlessly integrate pivotal trial data (CSRs, EDC extracts, ISS/ISE databases) with real-world evidence from FAERS, EudraVigilance, claims, and registries. The platform harmonizes heterogeneous data sources into a unified analytical framework, enabling direct comparison of trial safety profiles with background rates and comparator benchmarks from 100+ billion data points.
            </p>
            <ul class="arca-list" style="margin-bottom: var(--space-5);">
              <li>Automated ISS/ISE database ingestion and harmonization</li>
              <li>Real-world evidence integration for external validity</li>
              <li>Comparator benchmarking across approved and pipeline drugs</li>
            </ul>
            <a href="/platform-data-intelligence" class="arca-btn-tertiary">
              Explore Data Engine <span class="arca-arrow">&rarr;</span>
            </a>
          </div>

          <div class="arca-card arca-card-colored-top is-analytics" data-animate>
            <span class="arca-module-tag is-analytics">Decision Intelligence</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">
              Decision Intelligence for Phase III
            </h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">
              Implement BRAT framework and MCDA methodologies to generate structured benefit-risk assessments aligned with FDA and EMA expectations. Effects tables, forest plots, value trees, and sensitivity analyses are generated automatically from integrated data. Subpopulation analyses identify differential benefit-risk across age, sex, comorbidity, and geographic strata.
            </p>
            <ul class="arca-list" style="margin-bottom: var(--space-5);">
              <li>BRAT framework and EMA Effects Tables implementation</li>
              <li>Forest plots, value trees, and MCDA visualization</li>
              <li>Subpopulation and sensitivity analysis automation</li>
            </ul>
            <a href="/platform-ai-models" class="arca-btn-tertiary">
              Explore Decision Engine <span class="arca-arrow">&rarr;</span>
            </a>
          </div>

          <div class="arca-card arca-card-colored-top is-output" data-animate>
            <span class="arca-module-tag is-output">Automated Outputs</span>
            <h3 class="arca-heading-2" style="margin: var(--space-4) 0 var(--space-3);">
              Regulatory Outputs for Phase III
            </h3>
            <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-5);">
              Generate CTD Module 2.5 benefit-risk sections, integrated benefit-risk summaries, and advisory committee briefing materials formatted for FDA, EMA, and PMDA. All outputs maintain internal consistency with cross-referenced sections and automated version control. Scenario and sensitivity analyses are included to demonstrate robustness of benefit-risk conclusions.
            </p>
            <ul class="arca-list" style="margin-bottom: var(--space-5);">
              <li>CTD Module 2.5 clinical overview benefit-risk sections</li>
              <li>Advisory committee briefing analyses and visualizations</li>
              <li>Integrated benefit-risk summary documents</li>
            </ul>
            <a href="/platform-outputs" class="arca-btn-tertiary">
              Explore Outputs <span class="arca-arrow">&rarr;</span>
            </a>
          </div>

        </div>
      </div>
    </section>

        <div class="arca-section-divider" aria-hidden="true"></div>

<section class="arca-bg-grey-50 arca-bg-dots" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-8);">
          <p class="arca-section-label">Deliverables</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-4);">
            Typical Outputs for Phase III
          </h2>
          <p class="arca-body-lg arca-text-grey-600" style="max-width: 680px; margin: 0 auto;">
            ArcaScience generates submission-ready deliverables tailored to Phase III regulatory and strategic requirements.
          </p>
        </div>

        <div style="display: grid; grid-template-columns: repeat(3, 1fr); gap: 24px;">

          <div class="arca-card" data-animate style="text-align: center;">
            <div style="width: 56px; height: 56px; border-radius: 12px; background: var(--green-50); display: flex; align-items: center; justify-content: center; margin: 0 auto var(--space-4);">
              <svg width="28" height="28" viewBox="0 0 24 24" fill="none" stroke="var(--green-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <path d="M14 2H6a2 2 0 0 0-2 2v16a2 2 0 0 0 2 2h12a2 2 0 0 0 2-2V8z"/><polyline points="14 2 14 8 20 8"/>
              </svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">CTD Module 2.5 Benefit-Risk Sections</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Submission-ready clinical overview sections with integrated benefit-risk summaries formatted to FDA, EMA, and PMDA specifications.
            </p>
          </div>

          <div class="arca-card" data-animate style="text-align: center;">
            <div style="width: 56px; height: 56px; border-radius: 12px; background: var(--green-50); display: flex; align-items: center; justify-content: center; margin: 0 auto var(--space-4);">
              <svg width="28" height="28" viewBox="0 0 24 24" fill="none" stroke="var(--green-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <polyline points="22 12 18 12 15 21 9 3 6 12 2 12"/>
              </svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">Advisory Committee Briefing Analyses</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Quantitative benefit-risk presentations with forest plots, effects tables, and scenario analyses for FDA/EMA advisory committees.
            </p>
          </div>

          <div class="arca-card" data-animate style="text-align: center;">
            <div style="width: 56px; height: 56px; border-radius: 12px; background: var(--green-50); display: flex; align-items: center; justify-content: center; margin: 0 auto var(--space-4);">
              <svg width="28" height="28" viewBox="0 0 24 24" fill="none" stroke="var(--green-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <path d="M21 16V8a2 2 0 0 0-1-1.73l-7-4a2 2 0 0 0-2 0l-7 4A2 2 0 0 0 3 8v8a2 2 0 0 0 1 1.73l7 4a2 2 0 0 0 2 0l7-4A2 2 0 0 0 21 16z"/><polyline points="3.27 6.96 12 12.01 20.73 6.96"/><line x1="12" y1="22.08" x2="12" y2="12"/>
              </svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">Integrated Benefit-Risk Summary</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Comprehensive BRA synthesis with BRAT framework, MCDA results, and transparent documentation of analytical methodology.
            </p>
          </div>

          <div class="arca-card" data-animate style="text-align: center;">
            <div style="width: 56px; height: 56px; border-radius: 12px; background: var(--green-50); display: flex; align-items: center; justify-content: center; margin: 0 auto var(--space-4);">
              <svg width="28" height="28" viewBox="0 0 24 24" fill="none" stroke="var(--green-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <rect x="3" y="3" width="18" height="18" rx="2" ry="2"/><line x1="9" y1="9" x2="15" y2="15"/><line x1="15" y1="9" x2="9" y2="15"/>
              </svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">Sensitivity and Scenario Analysis Reports</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Robustness testing of benefit-risk conclusions across different assumptions, weighting schemes, and subpopulations.
            </p>
          </div>

          <div class="arca-card" data-animate style="text-align: center;">
            <div style="width: 56px; height: 56px; border-radius: 12px; background: var(--green-50); display: flex; align-items: center; justify-content: center; margin: 0 auto var(--space-4);">
              <svg width="28" height="28" viewBox="0 0 24 24" fill="none" stroke="var(--green-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <line x1="12" y1="1" x2="12" y2="23"/><path d="M17 5H9.5a3.5 3.5 0 0 0 0 7h5a3.5 3.5 0 0 1 0 7H6"/>
              </svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">Subpopulation Benefit-Risk Profiles</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Differential benefit-risk analyses by age, sex, race, comorbidity, and disease severity with regulatory implications.
            </p>
          </div>

          <div class="arca-card" data-animate style="text-align: center;">
            <div style="width: 56px; height: 56px; border-radius: 12px; background: var(--green-50); display: flex; align-items: center; justify-content: center; margin: 0 auto var(--space-4);">
              <svg width="28" height="28" viewBox="0 0 24 24" fill="none" stroke="var(--green-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <path d="M9 11l3 3L22 4"/><path d="M21 12v7a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2V5a2 2 0 0 1 2-2h11"/>
              </svg>
            </div>
            <h3 class="arca-heading-3" style="margin-bottom: var(--space-2);">Forest Plots and Visual Summaries</h3>
            <p class="arca-body-sm arca-text-grey-600">
              Publication-ready forest plots, value trees, and effects tables for regulatory briefings and advisory committee meetings.
            </p>
          </div>

        </div>
      </div>
    </section>
    <div class="arca-section-divider" aria-hidden="true"></div>


    <section class="arca-bg-grey-50 arca-bg-cross" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-8);">
          <p class="arca-section-label">Regulatory Context</p>
          <h2 class="arca-display-sm" style="margin-bottom: var(--space-4);">
            What Regulators Expect at Phase III
          </h2>
          <p class="arca-body-lg arca-text-grey-600" style="max-width: 680px; margin: 0 auto;">
            Understanding regulatory authority expectations for benefit-risk assessment at this phase is critical for successful submission and approval.
          </p>
        </div>

        <div style="max-width: 880px; margin: 0 auto;">

          <div class="arca-accordion-item" data-accordion data-animate>
            <button class="arca-accordion-trigger" aria-expanded="false" style="width: 100%; text-align: left; display: flex; justify-content: space-between; align-items: center; padding: var(--space-5); background: var(--white); border: 1px solid var(--grey-200); border-radius: 8px; margin-bottom: 12px; cursor: pointer; transition: all 0.2s;">
              <div style="display: flex; align-items: center; gap: 16px;">
                <img src="/images/badges/fda-logo.svg" alt="FDA" style="height: 32px; opacity: 0.7;">
                <h3 class="arca-heading-3">FDA (United States)</h3>
              </div>
              <svg class="arca-accordion-icon" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke="var(--grey-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" style="transition: transform 0.2s;">
                <polyline points="6 9 10 13 14 9"/>
              </svg>
            </button>
            <div class="arca-accordion-content" style="max-height: 0; overflow: hidden; transition: max-height 0.3s ease-out;">
              <div style="padding: var(--space-5); background: var(--white); border: 1px solid var(--grey-200); border-top: none; border-radius: 0 0 8px 8px; margin-top: -12px; margin-bottom: 12px;">
                <p class="arca-body-md arca-text-grey-600" style="margin-bottom: var(--space-4);">
                  FDA's benefit-risk assessment framework for Phase III emphasizes structured, transparent, and reproducible analysis. The BRAT framework—introduced in the 2021 guidance—requires sponsors to identify key benefits and risks, characterize evidence quality, and present integrated summaries with transparent reasoning. Advisory committees increasingly expect quantitative presentations including forest plots, subpopulation analyses, and sensitivity testing. ArcaScience directly implements the BRAT framework, generating structured benefit-risk assessments that align with FDA reviewer expectations and facilitate efficient regulatory review.
                </p>
                <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-3);">
                  <strong>Key FDA Guidance:</strong>
                </p>
                <ul class="arca-list">
                  <li>Benefit-Risk Assessment for New Drug and Biological Products (May 2021)</li>
                  <li>Structured Approach to Benefit-Risk Assessment in Drug Regulatory Decision-Making (February 2013)</li>
                </ul>
              </div>
            </div>
          </div>

          <div class="arca-accordion-item" data-accordion data-animate>
            <button class="arca-accordion-trigger" aria-expanded="false" style="width: 100%; text-align: left; display: flex; justify-content: space-between; align-items: center; padding: var(--space-5); background: var(--white); border: 1px solid var(--grey-200); border-radius: 8px; margin-bottom: 12px; cursor: pointer; transition: all 0.2s;">
              <div style="display: flex; align-items: center; gap: 16px;">
                <img src="/images/badges/ema-logo.svg" alt="EMA" style="height: 32px; opacity: 0.7;">
                <h3 class="arca-heading-3">EMA (European Union)</h3>
              </div>
              <svg class="arca-accordion-icon" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke="var(--grey-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" style="transition: transform 0.2s;">
                <polyline points="6 9 10 13 14 9"/>
              </svg>
            </button>
            <div class="arca-accordion-content" style="max-height: 0; overflow: hidden; transition: max-height 0.3s ease-out;">
              <div style="padding: var(--space-5); background: var(--white); border: 1px solid var(--grey-200); border-top: none; border-radius: 0 0 8px 8px; margin-top: -12px; margin-bottom: 12px;">
                <p class="arca-body-md arca-text-grey-600" style="margin-bottom: var(--space-4);">
                  EMA's benefit-risk methodology emphasizes the Effects Table as the central tool for structured assessment. CHMP assessment reports require comprehensive effects tables that display all key benefits and risks with evidence quality ratings, effect sizes, and uncertainties. EMA reviewers expect sponsors to address patient perspective, comparative effectiveness against standard of care, and transparent weighting of benefit-risk criteria. The platform's automated effects table generation ensures compliance with EMA's structured methodology and facilitates rapid response to CHMP questions during review.
                </p>
                <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-3);">
                  <strong>Key EMA Guidance:</strong>
                </p>
                <ul class="arca-list">
                  <li>Benefit-risk methodology project: Final report (EMA/549682/2013)</li>
                  <li>Guideline on Good Pharmacovigilance Practices (GVP) – Module VIII (Rev 3)</li>
                </ul>
              </div>
            </div>
          </div>

          <div class="arca-accordion-item" data-accordion data-animate>
            <button class="arca-accordion-trigger" aria-expanded="false" style="width: 100%; text-align: left; display: flex; justify-content: space-between; align-items: center; padding: var(--space-5); background: var(--white); border: 1px solid var(--grey-200); border-radius: 8px; margin-bottom: 12px; cursor: pointer; transition: all 0.2s;">
              <div style="display: flex; align-items: center; gap: 16px;">
                <img src="/images/badges/pmda-logo.svg" alt="PMDA" style="height: 32px; opacity: 0.7;">
                <h3 class="arca-heading-3">PMDA (Japan)</h3>
              </div>
              <svg class="arca-accordion-icon" width="20" height="20" viewBox="0 0 20 20" fill="none" stroke="var(--grey-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" style="transition: transform 0.2s;">
                <polyline points="6 9 10 13 14 9"/>
              </svg>
            </button>
            <div class="arca-accordion-content" style="max-height: 0; overflow: hidden; transition: max-height 0.3s ease-out;">
              <div style="padding: var(--space-5); background: var(--white); border: 1px solid var(--grey-200); border-top: none; border-radius: 0 0 8px 8px; margin-top: -12px; margin-bottom: 12px;">
                <p class="arca-body-md arca-text-grey-600" style="margin-bottom: var(--space-4);">
                  PMDA's approach to Phase III benefit-risk assessment emphasizes demonstration that trial results from foreign populations are applicable to Japanese patients. Sponsors must address ethnic factors, comparative effectiveness against treatments commonly used in Japan, and benefit-risk considerations specific to Japanese clinical practice patterns. PMDA reviewers expect clear documentation of how subpopulation analyses address potential ethnic differences in efficacy or safety. The platform's subpopulation analytics support PMDA's requirements for ethnic factor assessment and enable sponsors to demonstrate consistency of benefit-risk across global populations including Japanese patients.
                </p>
                <p class="arca-body-sm arca-text-grey-600" style="margin-bottom: var(--space-3);">
                  <strong>Key PMDA Guidance:</strong>
                </p>
                <ul class="arca-list">
                  <li>Basic Principles on Global Clinical Trials (PFSB/ELD Notification 0928 No. 2)</li>
                  <li>Guideline on Risk Management Plan (Yakushokuhatsu 0430 No. 1, April 2012)</li>
                </ul>
              </div>
            </div>
          </div>

        </div>

      </div>
    </section>

        <div class="arca-section-divider" aria-hidden="true"></div>

<section class="arca-bg-blue-50 arca-bg-lines" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 64px; align-items: start;">

          <div>
            <p class="arca-section-label">Phase III Case Study</p>
            <h2 class="arca-heading-1" style="margin-bottom: var(--space-5);">
              Accelerated Advisory Committee Preparation for Novel Oncology Therapy
            </h2>
            <p class="arca-body-md arca-text-grey-600" style="margin-bottom: var(--space-5);">
              A biotech company's novel immunotherapy for refractory melanoma completed two pivotal Phase III trials with promising efficacy but concerning immune-related adverse events (irAEs). The FDA scheduled an Oncologic Drugs Advisory Committee (ODAC) meeting in 12 weeks—requiring comprehensive benefit-risk analysis, forest plots, subpopulation analyses, and scenario modeling under extreme time pressure.
            </p>
            <p class="arca-body-md arca-text-grey-600" style="margin-bottom: var(--space-5);">
              ArcaScience integrated the pivotal trial data with real-world evidence on irAE management, standard-of-care outcomes, and comparator profiles. The platform generated BRAT-aligned benefit-risk frameworks, forest plots showing net clinical benefit across subpopulations, and sensitivity analyses testing different irAE weighting assumptions. The automated outputs enabled the sponsor to submit advisory committee briefing materials 3 weeks early, receive positive ODAC recommendation (14-2 vote), and secure approval with a comprehensive Risk Evaluation and Mitigation Strategy (REMS) based on the platform's quantitative benefit-risk analysis.
            </p>

            <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 24px; margin-bottom: var(--space-6);">
              <div>
                <span class="arca-stat-sm" style="color: var(--indigo-600);" data-countup="3">0</span>
                <p class="arca-caption arca-text-grey-600">Weeks ahead of ODAC submission deadline</p>
              </div>
              <div>
                <span class="arca-stat-sm" style="color: var(--indigo-600);">14-2</span>
                <p class="arca-caption arca-text-grey-600">ODAC favorable vote outcome</p>
              </div>
            </div>

            <a href="/evidence-case-studies-hub" class="arca-btn-tertiary">
              Read Full Case Study <span class="arca-arrow">&rarr;</span>
            </a>
          </div>

          <div>
            <div class="arca-card" style="background: var(--blue-50); border-color: var(--blue-200);">
              <div class="arca-testimonial-quote" style="padding-left: 24px; border-left: 3px solid var(--blue-400); margin-bottom: var(--space-5);">
                <p class="arca-body-md" style="font-style: italic; color: var(--grey-700);">
                  "The ArcaScience platform was transformational for our advisory committee preparation. We faced a 12-week deadline to synthesize complex pivotal trial data into quantitative benefit-risk presentations that would satisfy FDA and ODAC panelists. The automated BRAT framework implementation, forest plots, and subpopulation analyses gave us confidence that our benefit-risk story was bulletproof. We submitted 3 weeks early and received a strongly favorable ODAC vote. I cannot imagine preparing that submission manually in that timeframe."
                </p>
              </div>
              <div class="arca-testimonial-attribution">
                <p class="arca-body-md" style="font-weight: 600;">Dr. Jennifer Williams</p>
                <p class="arca-body-sm arca-text-grey-600">Chief Medical Officer</p>
                <p class="arca-body-sm arca-text-grey-600">Emerging Biotech — Immuno-Oncology</p>
              </div>
            </div>

            <div class="arca-card" style="margin-top: var(--space-5); text-align: center;">
              <span class="arca-stat-lg" style="color: var(--indigo-600);" data-countup="89">0</span>
              <p class="arca-caption arca-text-grey-600">Phase III programs supported</p>
            </div>
          </div>

        </div>
      </div>
    </section>
    <div class="arca-section-divider" aria-hidden="true"></div>


    <section class="arca-bg-grey-50 arca-bg-cross" style="padding: var(--space-9) 0;" data-animate>
      <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
        <div style="text-align: center; margin-bottom: var(--space-8);">
          <p class="arca-section-label">Lifecycle Navigation</p>
          <h2 class="arca-heading-2">Explore Adjacent Development Phases</h2>
        </div>

        <div style="display: grid; grid-template-columns: repeat(2, 1fr); gap: 24px; max-width: 920px; margin: 0 auto;">

          <a href="/phase-2" class="arca-card" style="text-decoration: none; color: inherit; display: flex; align-items: center; gap: 16px; transition: all 0.2s; border: 2px solid var(--grey-200);" data-animate>
            <div style="width: 48px; height: 48px; border-radius: 8px; background: var(--grey-100); display: flex; align-items: center; justify-content: center; flex-shrink: 0;">
              <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="var(--grey-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <polyline points="15 18 9 12 15 6"/>
              </svg>
            </div>
            <div>
              <p class="arca-caption arca-text-grey-600" style="margin-bottom: 4px;">Previous Phase</p>
              <h3 class="arca-heading-3">Phase II</h3>
            </div>
          </a>

          <a href="/phase-submission" class="arca-card" style="text-decoration: none; color: inherit; display: flex; align-items: center; gap: 16px; transition: all 0.2s; border: 2px solid var(--grey-200); justify-content: space-between;" data-animate>
            <div>
              <p class="arca-caption arca-text-grey-600" style="margin-bottom: 4px;">Next Phase</p>
              <h3 class="arca-heading-3">Regulatory Submission</h3>
            </div>
            <div style="width: 48px; height: 48px; border-radius: 8px; background: var(--grey-100); display: flex; align-items: center; justify-content: center; flex-shrink: 0;">
              <svg width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="var(--grey-600)" stroke-width="2" stroke-linecap="round" stroke-linejoin="round">
                <polyline points="9 18 15 12 9 6"/>
              </svg>
            </div>
          </a>

        </div>

        <div style="text-align: center; margin-top: var(--space-6);">
          <a href="/solution-lifecycle-phase" class="arca-btn-tertiary">
            View All Lifecycle Phases <span class="arca-arrow">&rarr;</span>
          </a>
        </div>

      </div>
    </section>

    <section class="arca-cta-section" data-animate style="position: relative; overflow: hidden;">

      <!-- arca-decor: CTA glow orbs -->
      <div style="position: absolute; top: -60px; left: -60px; width: 300px; height: 300px; background: radial-gradient(circle, rgba(255,255,255,0.08) 0%, transparent 70%); border-radius: 50%; filter: blur(40px); pointer-events: none; animation: as-float 7s ease-in-out infinite; z-index: 0;"></div>
      <div style="position: absolute; bottom: -40px; right: -40px; width: 250px; height: 250px; background: radial-gradient(circle, rgba(255,255,255,0.06) 0%, transparent 70%); border-radius: 50%; filter: blur(40px); pointer-events: none; animation: as-float 9s ease-in-out infinite reverse; z-index: 0;"></div>

      <div style="position: relative; z-index: 1; max-width: 680px; margin: 0 auto; padding: 0 24px;">
        <h2 class="arca-heading-1" style="margin-bottom: var(--space-5);">
          See ArcaScience Applied to Phase III
        </h2>
        <p class="arca-body-lg" style="margin-bottom: var(--space-7);">
          Request a demonstration customized to your Phase III program. Our scientists will show you how the platform ingests your data, applies phase-specific BRA frameworks, and generates regulatory-ready outputs for this development stage.
        </p>
        <div style="display: flex; gap: 16px; justify-content: center; flex-wrap: wrap;">
          <a href="/contact?source=phase-3" class="arca-btn-primary-inverted">
            Discuss Your Registration Strategy
          </a>
          <a href="/platform-overview" class="arca-btn-secondary" style="border-color: rgba(255,255,255,0.3); color: var(--white);">
            Explore the Platform <span class="arca-arrow">&rarr;</span>
          </a>
        </div>
      </div>
    </section>

  </main>

  <footer class="arca-bg-blue-900" style="padding: var(--space-9) 0 var(--space-7);">
    <div style="max-width: var(--content-max-width); margin: 0 auto; padding: 0 24px;">
      <div style="display: grid; grid-template-columns: 2fr 1fr 1fr 1fr 1fr; gap: 48px;">

        <div>
          <img src="/images/arcascience-logo-white.svg" alt="ArcaScience" height="28" style="margin-bottom: var(--space-5);">
          <p class="arca-body-sm" style="color: rgba(255,255,255,0.65); max-width: 280px;">
            AI-driven benefit-risk analysis for pharmaceutical development. Founded 2018.
          </p>
        </div>

        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Platform</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/platform-overview" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Overview</a>
            <a href="/platform-data-intelligence" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Data Intelligence</a>
            <a href="/platform-ai-models" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Decision Intelligence</a>
            <a href="/platform-outputs" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Regulatory Outputs</a>
            <a href="/security-compliance" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Security & Compliance</a>
          </nav>
        </div>

        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Solutions</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/solution-therapeutic-area" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Therapeutic Areas</a>
            <a href="/ta-oncology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Oncology</a>
            <a href="/ta-neurology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Neurology</a>
            <a href="/ta-immunology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Immunology</a>
            <a href="/ta-cardiology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Cardiology</a>
            <a href="/ta-respiratory" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Respiratory</a>
            <a href="/ta-rare-diseases" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Rare Diseases</a>
            <a href="/ta-dermatology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Dermatology</a>
            <a href="/ta-hematology" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Hematology</a>
          </nav>
        </div>

        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Company</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/about" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">About</a>
            <a href="/leadership" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Team</a>
            <a href="/careers" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Careers</a>
            <a href="/about" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">News</a>
            <a href="/contact" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Contact</a>
          </nav>
        </div>

        <div>
          <p class="arca-label" style="color: rgba(255,255,255,0.45); margin-bottom: var(--space-4);">Resources</p>
          <nav style="display: flex; flex-direction: column; gap: 12px;">
            <a href="/evidence-case-studies-hub" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Case Studies</a>
            <a href="/resources-whitepapers" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Whitepapers</a>
            <a href="/resources" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Blog</a>
            <a href="/resources" style="color: rgba(255,255,255,0.65); text-decoration: none; font-size: 0.875rem;">Documentation</a>
          </nav>
        </div>

      </div>

      <div style="margin-top: var(--space-8); padding-top: var(--space-5); border-top: 1px solid rgba(255,255,255,0.1); display: flex; justify-content: space-between; align-items: center;">
        <p class="arca-caption" style="color: rgba(255,255,255,0.45);">
          &copy; 2026 ArcaScience. All rights reserved.
        </p>
        <div style="display: flex; gap: 24px;">
          <a href="/legal-privacy" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Privacy</a>
          <a href="/legal-terms" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Terms</a>
          <a href="/legal-cookies" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Cookies</a>
          <a href="/legal-accessibility" style="color: rgba(255,255,255,0.45); text-decoration: none; font-size: 0.75rem;">Accessibility</a>
        </div>
      </div>
    </div>
  </footer>

  <button data-back-to-top aria-label="Back to top">
    <svg width="16" height="16" viewBox="0 0 16 16" fill="none"><path d="M8 12V4M4 7l4-4 4 4" stroke="currentColor" stroke-width="1.5" stroke-linecap="round"/></svg>
  </button>

  <script src="/dist/arcascience-global.min.js" defer></script>
  <script src="/dist/arcascience-countup.min.js" defer></script>
  <script>
    document.addEventListener('DOMContentLoaded', function() {
      if (window.ArcaScience) ArcaScience.init();
      if (window.ArcaScienceCountUp) ArcaScienceCountUp.init({ selector: '[data-countup]' });

      document.querySelectorAll('[data-accordion]').forEach(item => {
        const trigger = item.querySelector('.arca-accordion-trigger');
        const content = item.querySelector('.arca-accordion-content');
        const icon = item.querySelector('.arca-accordion-icon');

        trigger.addEventListener('click', () => {
          const expanded = trigger.getAttribute('aria-expanded') === 'true';

          document.querySelectorAll('[data-accordion]').forEach(otherItem => {
            if (otherItem !== item) {
              const otherTrigger = otherItem.querySelector('.arca-accordion-trigger');
              const otherContent = otherItem.querySelector('.arca-accordion-content');
              const otherIcon = otherItem.querySelector('.arca-accordion-icon');
              otherTrigger.setAttribute('aria-expanded', 'false');
              otherContent.style.maxHeight = '0';
              otherIcon.style.transform = 'rotate(0deg)';
            }
          });

          trigger.setAttribute('aria-expanded', !expanded);
          content.style.maxHeight = expanded ? '0' : content.scrollHeight + 'px';
          icon.style.transform = expanded ? 'rotate(0deg)' : 'rotate(180deg)';
        });
      });
    });
  </script>

</body>
</html>
